The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06535438

Enrollment

1000

Registered

2024-08-02

Start date

2024-08-01

Completion date

2024-08-31

Last updated

2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage

Keywords

ICH

Brief summary

The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage. The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age≥18 years 2. had completed a CT examination within 24 h of disease onset; 3. had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.

Exclusion criteria

1. had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors; 2. had ischemic cerebral infarction hemorrhagic transformation; 3. had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination; 4. had images of poor quality that could notbe accurately evaluated; 5. had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).

Design outcomes

Primary

Measure	Time frame	Description
The prognosis of cerebral hemorrhage at 90 days	90 days	The Modified Rankin Scale was used to evaluate the prognosis of the patients, and MRS Score \>2 indicated poor prognosis

Outcome results